Instrument Inactif

Autres langues Arix Bioscience plc

Actions

ARIX

GB00BD045071

Gestion des placements et exploitants de fonds

Autres langues

11/03/24	Merck Sharp & Dohme LLC completed the acquisition of Harpoon Therapeutics, Inc..
14/02/24	RTW Biotech Opportunities NAV increases 2.5% in January
13/02/24	RTW Biotech Opportunities Completes Arix Bioscience Acquisition
13/02/24	RTW Biotech Opportunities Ltd a fund managed by RTW Investments, LP completed the acquisition of Arix Biosciences Plc's assets from Arix Bioscience plc.
12/02/24	Katoro Gold launches fundraising, eyes board shake-up
12/02/24	Arix Bioscience's Asset Sale to RTW Biotech Takes Effect
12/02/24	Arix Bioscience shares suspended ahead of RTW takeover
12/02/24	Arix Bioscience Shares to be Suspended on London Exchange Amid Acquisition
29/01/24	Arix Bioscience Shareholders Approve Asset Sale to RTW Biotech
23/01/24	Arix Bioscience Gains UK Regulatory Approval for Sale to RTW Biotech
22/01/24	RTW Biotech completes Arix investment in takeover run-up
22/01/24	RTW Biotech Buys Minority Stake in Arix Bioscience to Support Planned Takeover
22/01/24	Arix Bioscience plc Announces Resignation of Directors
19/01/24	Arix Bioscience eyes USD19 million return from Harpoon sale
19/01/24	Arix Bioscience Flags Proceeds from Merck's Purchase of Harpoon Therapeutics
19/01/24	Rtw Biotech Opportunities Operating Ltd completed the acquisition of a 26.6% stake in Arix Bioscience plc from Acacia Research Corporation for £47.2 million.
09/01/24	Arix Bioscience's Portfolio Company Signs $680 Million Takeover Deal with Merck & Co.
08/01/24	Merck Sharp & Dohme LLC entered into an agreement to acquire Harpoon Therapeutics, Inc. for $410 million.
08/12/23	Arix Bioscience's Portfolio Company Doses First Patient in Late-stage Trial of Choroidal Melanoma Therapy
01/12/23	RTW Biotech Opportunities Ltd a fund managed by RTW Investments, LP agreed to acquire Arix Biosciences Plc's assets from Arix Bioscience plc for £190 million.
01/11/23	FTSE 100 Closes Up 0.28% as Interest Rate Rise Fears Start to Ease
01/11/23	RTW Biotech agrees "immediately accretive" Arix Bioscience takeover
01/11/23	RTW Biotech Opportunities, Arix Bioscience Agree on Potential Merger Terms
01/11/23	Rtw Biotech Opportunities Operating Ltd enter into an agreement to acquire 26.6% stake in Arix Bioscience plc from Acacia Research Corporation for £47.2 million.
25/10/23	Gran Tierra completes offers, Pensana wins grant